福元医药(601089.SH)：前三季度净利润3.75亿元，同比下降6.39%

Core Viewpoint - Fuyuan Pharmaceutical (601089.SH) reported a decline in revenue and net profit for the first three quarters of 2025 compared to the previous year [1] Financial Performance - The total operating revenue for the first three quarters reached 2.521 billion yuan, representing a year-on-year decrease of 1.04% [1] - The net profit attributable to shareholders of the parent company was 375 million yuan, down 6.39% year-on-year [1] - The basic earnings per share stood at 0.78 yuan [1]